nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—migraine—Acetylsalicylic acid—coronary artery disease	0.338	1	CpDpCtD
Cyproheptadine—HTR2A—coronary artery disease	0.101	1	CbGaD
Cyproheptadine—UGT1A3—Pitavastatin—coronary artery disease	0.0717	0.214	CbGbCtD
Cyproheptadine—UGT1A3—Ezetimibe—coronary artery disease	0.0529	0.157	CbGbCtD
Cyproheptadine—UGT1A3—Simvastatin—coronary artery disease	0.0492	0.146	CbGbCtD
Cyproheptadine—UGT1A3—Lovastatin—coronary artery disease	0.0481	0.143	CbGbCtD
Cyproheptadine—UGT1A3—Atorvastatin—coronary artery disease	0.0438	0.13	CbGbCtD
Cyproheptadine—UGT1A3—Losartan—coronary artery disease	0.0401	0.119	CbGbCtD
Cyproheptadine—HTR1A—Penbutolol—coronary artery disease	0.0301	0.0897	CbGbCtD
Cyproheptadine—HTR2B—cardial valve—coronary artery disease	0.00708	0.288	CbGeAlD
Cyproheptadine—SLC6A2—sympathetic nervous system—coronary artery disease	0.00248	0.101	CbGeAlD
Cyproheptadine—HTR2A—arteriole—coronary artery disease	0.00234	0.0949	CbGeAlD
Cyproheptadine—SLC6A2—autonomic nervous system—coronary artery disease	0.00166	0.0676	CbGeAlD
Cyproheptadine—HTR2A—pulmonary artery—coronary artery disease	0.00153	0.0622	CbGeAlD
Cyproheptadine—HTR2A—sympathetic nervous system—coronary artery disease	0.00149	0.0605	CbGeAlD
Cyproheptadine—HTR2A—vagus nerve—coronary artery disease	0.00144	0.0586	CbGeAlD
Cyproheptadine—HTR2A—vein—coronary artery disease	0.00139	0.0566	CbGeAlD
Cyproheptadine—HTR2A—autonomic nervous system—coronary artery disease	0.001	0.0407	CbGeAlD
Cyproheptadine—Phenindione—VKORC1—coronary artery disease	0.000947	0.285	CrCbGaD
Cyproheptadine—Cyclizine—SULT1E1—coronary artery disease	0.000629	0.189	CrCbGaD
Cyproheptadine—HTR2A—artery—coronary artery disease	0.000567	0.0231	CbGeAlD
Cyproheptadine—HTR2A—endothelium—coronary artery disease	0.000479	0.0195	CbGeAlD
Cyproheptadine—CHRM2—heart—coronary artery disease	0.000432	0.0176	CbGeAlD
Cyproheptadine—CHRM2—cardiovascular system—coronary artery disease	0.000408	0.0166	CbGeAlD
Cyproheptadine—HTR2B—heart—coronary artery disease	0.000391	0.0159	CbGeAlD
Cyproheptadine—CHRM1—cardiovascular system—coronary artery disease	0.000371	0.0151	CbGeAlD
Cyproheptadine—HTR2B—cardiovascular system—coronary artery disease	0.000369	0.015	CbGeAlD
Cyproheptadine—HTR1A—cardiovascular system—coronary artery disease	0.000331	0.0134	CbGeAlD
Cyproheptadine—HTR2B—blood—coronary artery disease	0.000292	0.0119	CbGeAlD
Cyproheptadine—Ketotifen—PDE4B—coronary artery disease	0.000264	0.0795	CrCbGaD
Cyproheptadine—Carbamazepine—RALBP1—coronary artery disease	0.000261	0.0784	CrCbGaD
Cyproheptadine—Mianserin—HRH2—coronary artery disease	0.000209	0.0628	CrCbGaD
Cyproheptadine—HTR2A—heart—coronary artery disease	0.000209	0.00849	CbGeAlD
Cyproheptadine—HTR2A—cardiovascular system—coronary artery disease	0.000197	0.00801	CbGeAlD
Cyproheptadine—Loxapine—HRH2—coronary artery disease	0.000166	0.0499	CrCbGaD
Cyproheptadine—HTR2A—blood—coronary artery disease	0.000156	0.00633	CbGeAlD
Cyproheptadine—Amitriptyline—HRH2—coronary artery disease	0.00013	0.039	CrCbGaD
Cyproheptadine—Fatigue—Captopril—coronary artery disease	9.12e-05	0.000812	CcSEcCtD
Cyproheptadine—Vertigo—Ramipril—coronary artery disease	9.1e-05	0.00081	CcSEcCtD
Cyproheptadine—Feeling abnormal—Enalapril—coronary artery disease	9.09e-05	0.000809	CcSEcCtD
Cyproheptadine—Syncope—Ramipril—coronary artery disease	9.08e-05	0.000808	CcSEcCtD
Cyproheptadine—Leukopenia—Ramipril—coronary artery disease	9.06e-05	0.000807	CcSEcCtD
Cyproheptadine—Urticaria—Pravastatin—coronary artery disease	9.06e-05	0.000807	CcSEcCtD
Cyproheptadine—Asthenia—Simvastatin—coronary artery disease	9.05e-05	0.000806	CcSEcCtD
Cyproheptadine—Diarrhoea—Ezetimibe—coronary artery disease	9.05e-05	0.000806	CcSEcCtD
Cyproheptadine—Constipation—Captopril—coronary artery disease	9.05e-05	0.000806	CcSEcCtD
Cyproheptadine—Dyspepsia—Perindopril—coronary artery disease	9.04e-05	0.000805	CcSEcCtD
Cyproheptadine—Tension—Lisinopril—coronary artery disease	9.01e-05	0.000802	CcSEcCtD
Cyproheptadine—Hypotension—Losartan—coronary artery disease	9.01e-05	0.000802	CcSEcCtD
Cyproheptadine—Dizziness—Clopidogrel—coronary artery disease	8.98e-05	0.000799	CcSEcCtD
Cyproheptadine—Paraesthesia—Furosemide—coronary artery disease	8.97e-05	0.000798	CcSEcCtD
Cyproheptadine—Feeling abnormal—Telmisartan—coronary artery disease	8.97e-05	0.000798	CcSEcCtD
Cyproheptadine—Palpitations—Ramipril—coronary artery disease	8.95e-05	0.000796	CcSEcCtD
Cyproheptadine—Decreased appetite—Perindopril—coronary artery disease	8.93e-05	0.000795	CcSEcCtD
Cyproheptadine—Dizziness—Lovastatin—coronary artery disease	8.92e-05	0.000794	CcSEcCtD
Cyproheptadine—Nervousness—Lisinopril—coronary artery disease	8.92e-05	0.000794	CcSEcCtD
Cyproheptadine—Loss of consciousness—Ramipril—coronary artery disease	8.9e-05	0.000792	CcSEcCtD
Cyproheptadine—Vertigo—Timolol—coronary artery disease	8.89e-05	0.000792	CcSEcCtD
Cyproheptadine—Somnolence—Furosemide—coronary artery disease	8.88e-05	0.00079	CcSEcCtD
Cyproheptadine—Syncope—Timolol—coronary artery disease	8.88e-05	0.00079	CcSEcCtD
Cyproheptadine—Diarrhoea—Eplerenone—coronary artery disease	8.86e-05	0.000789	CcSEcCtD
Cyproheptadine—Fatigue—Perindopril—coronary artery disease	8.86e-05	0.000789	CcSEcCtD
Cyproheptadine—Urticaria—Trandolapril—coronary artery disease	8.8e-05	0.000783	CcSEcCtD
Cyproheptadine—Constipation—Perindopril—coronary artery disease	8.79e-05	0.000782	CcSEcCtD
Cyproheptadine—Vomiting—Fenofibrate—coronary artery disease	8.78e-05	0.000782	CcSEcCtD
Cyproheptadine—Convulsion—Ramipril—coronary artery disease	8.77e-05	0.000781	CcSEcCtD
Cyproheptadine—Urticaria—Enalapril—coronary artery disease	8.77e-05	0.00078	CcSEcCtD
Cyproheptadine—Dizziness—Ezetimibe—coronary artery disease	8.75e-05	0.000779	CcSEcCtD
Cyproheptadine—Palpitations—Timolol—coronary artery disease	8.75e-05	0.000779	CcSEcCtD
Cyproheptadine—Feeling abnormal—Captopril—coronary artery disease	8.72e-05	0.000776	CcSEcCtD
Cyproheptadine—Insomnia—Losartan—coronary artery disease	8.72e-05	0.000776	CcSEcCtD
Cyproheptadine—Rash—Fenofibrate—coronary artery disease	8.71e-05	0.000775	CcSEcCtD
Cyproheptadine—Dermatitis—Fenofibrate—coronary artery disease	8.7e-05	0.000775	CcSEcCtD
Cyproheptadine—Loss of consciousness—Timolol—coronary artery disease	8.7e-05	0.000774	CcSEcCtD
Cyproheptadine—Decreased appetite—Furosemide—coronary artery disease	8.68e-05	0.000773	CcSEcCtD
Cyproheptadine—Headache—Fenofibrate—coronary artery disease	8.65e-05	0.00077	CcSEcCtD
Cyproheptadine—Vision blurred—Lisinopril—coronary artery disease	8.65e-05	0.00077	CcSEcCtD
Cyproheptadine—Paraesthesia—Losartan—coronary artery disease	8.65e-05	0.00077	CcSEcCtD
Cyproheptadine—Urticaria—Telmisartan—coronary artery disease	8.65e-05	0.00077	CcSEcCtD
Cyproheptadine—Vomiting—Clopidogrel—coronary artery disease	8.63e-05	0.000769	CcSEcCtD
Cyproheptadine—Diarrhoea—Simvastatin—coronary artery disease	8.63e-05	0.000768	CcSEcCtD
Cyproheptadine—Fatigue—Furosemide—coronary artery disease	8.61e-05	0.000767	CcSEcCtD
Cyproheptadine—Tremor—Lisinopril—coronary artery disease	8.6e-05	0.000766	CcSEcCtD
Cyproheptadine—Vomiting—Lovastatin—coronary artery disease	8.58e-05	0.000763	CcSEcCtD
Cyproheptadine—Somnolence—Losartan—coronary artery disease	8.57e-05	0.000763	CcSEcCtD
Cyproheptadine—Dizziness—Eplerenone—coronary artery disease	8.56e-05	0.000762	CcSEcCtD
Cyproheptadine—Rash—Clopidogrel—coronary artery disease	8.56e-05	0.000762	CcSEcCtD
Cyproheptadine—Dermatitis—Clopidogrel—coronary artery disease	8.55e-05	0.000761	CcSEcCtD
Cyproheptadine—Asthenia—Valsartan—coronary artery disease	8.55e-05	0.000761	CcSEcCtD
Cyproheptadine—Constipation—Furosemide—coronary artery disease	8.54e-05	0.00076	CcSEcCtD
Cyproheptadine—Asthenia—Olmesartan—coronary artery disease	8.51e-05	0.000757	CcSEcCtD
Cyproheptadine—Headache—Clopidogrel—coronary artery disease	8.51e-05	0.000757	CcSEcCtD
Cyproheptadine—Rash—Lovastatin—coronary artery disease	8.51e-05	0.000757	CcSEcCtD
Cyproheptadine—Dermatitis—Lovastatin—coronary artery disease	8.5e-05	0.000756	CcSEcCtD
Cyproheptadine—Dyspepsia—Losartan—coronary artery disease	8.48e-05	0.000755	CcSEcCtD
Cyproheptadine—Feeling abnormal—Perindopril—coronary artery disease	8.47e-05	0.000754	CcSEcCtD
Cyproheptadine—Headache—Lovastatin—coronary artery disease	8.45e-05	0.000752	CcSEcCtD
Cyproheptadine—Vomiting—Ezetimibe—coronary artery disease	8.41e-05	0.000749	CcSEcCtD
Cyproheptadine—Decreased appetite—Losartan—coronary artery disease	8.38e-05	0.000746	CcSEcCtD
Cyproheptadine—Dizziness—Simvastatin—coronary artery disease	8.34e-05	0.000743	CcSEcCtD
Cyproheptadine—Rash—Ezetimibe—coronary artery disease	8.34e-05	0.000743	CcSEcCtD
Cyproheptadine—Dermatitis—Ezetimibe—coronary artery disease	8.33e-05	0.000742	CcSEcCtD
Cyproheptadine—Confusional state—Ramipril—coronary artery disease	8.33e-05	0.000742	CcSEcCtD
Cyproheptadine—Asthenia—Niacin—coronary artery disease	8.31e-05	0.00074	CcSEcCtD
Cyproheptadine—Fatigue—Losartan—coronary artery disease	8.31e-05	0.00074	CcSEcCtD
Cyproheptadine—Headache—Ezetimibe—coronary artery disease	8.29e-05	0.000738	CcSEcCtD
Cyproheptadine—Oedema—Ramipril—coronary artery disease	8.26e-05	0.000736	CcSEcCtD
Cyproheptadine—Vertigo—Lisinopril—coronary artery disease	8.25e-05	0.000734	CcSEcCtD
Cyproheptadine—Constipation—Losartan—coronary artery disease	8.24e-05	0.000734	CcSEcCtD
Cyproheptadine—Syncope—Lisinopril—coronary artery disease	8.23e-05	0.000733	CcSEcCtD
Cyproheptadine—Vomiting—Eplerenone—coronary artery disease	8.23e-05	0.000733	CcSEcCtD
Cyproheptadine—Feeling abnormal—Furosemide—coronary artery disease	8.23e-05	0.000733	CcSEcCtD
Cyproheptadine—Leukopenia—Lisinopril—coronary artery disease	8.22e-05	0.000732	CcSEcCtD
Cyproheptadine—Nausea—Fenofibrate—coronary artery disease	8.21e-05	0.00073	CcSEcCtD
Cyproheptadine—Asthenia—Pravastatin—coronary artery disease	8.18e-05	0.000729	CcSEcCtD
Cyproheptadine—Rash—Eplerenone—coronary artery disease	8.17e-05	0.000727	CcSEcCtD
Cyproheptadine—Urticaria—Perindopril—coronary artery disease	8.16e-05	0.000727	CcSEcCtD
Cyproheptadine—Dermatitis—Eplerenone—coronary artery disease	8.16e-05	0.000726	CcSEcCtD
Cyproheptadine—Diarrhoea—Valsartan—coronary artery disease	8.15e-05	0.000726	CcSEcCtD
Cyproheptadine—Confusional state—Timolol—coronary artery disease	8.15e-05	0.000725	CcSEcCtD
Cyproheptadine—Shock—Ramipril—coronary artery disease	8.13e-05	0.000724	CcSEcCtD
Cyproheptadine—Palpitations—Lisinopril—coronary artery disease	8.11e-05	0.000722	CcSEcCtD
Cyproheptadine—Diarrhoea—Olmesartan—coronary artery disease	8.11e-05	0.000722	CcSEcCtD
Cyproheptadine—Headache—Eplerenone—coronary artery disease	8.11e-05	0.000722	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Ramipril—coronary artery disease	8.09e-05	0.00072	CcSEcCtD
Cyproheptadine—Oedema—Timolol—coronary artery disease	8.08e-05	0.000719	CcSEcCtD
Cyproheptadine—Loss of consciousness—Lisinopril—coronary artery disease	8.07e-05	0.000718	CcSEcCtD
Cyproheptadine—Nausea—Clopidogrel—coronary artery disease	8.07e-05	0.000718	CcSEcCtD
Cyproheptadine—Tachycardia—Ramipril—coronary artery disease	8.07e-05	0.000718	CcSEcCtD
Cyproheptadine—Vomiting—Simvastatin—coronary artery disease	8.02e-05	0.000714	CcSEcCtD
Cyproheptadine—Nausea—Lovastatin—coronary artery disease	8.01e-05	0.000713	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Ramipril—coronary artery disease	7.99e-05	0.000711	CcSEcCtD
Cyproheptadine—Rash—Simvastatin—coronary artery disease	7.96e-05	0.000708	CcSEcCtD
Cyproheptadine—Dermatitis—Simvastatin—coronary artery disease	7.95e-05	0.000708	CcSEcCtD
Cyproheptadine—Asthenia—Trandolapril—coronary artery disease	7.95e-05	0.000707	CcSEcCtD
Cyproheptadine—Shock—Timolol—coronary artery disease	7.95e-05	0.000707	CcSEcCtD
Cyproheptadine—Feeling abnormal—Losartan—coronary artery disease	7.94e-05	0.000707	CcSEcCtD
Cyproheptadine—Urticaria—Furosemide—coronary artery disease	7.93e-05	0.000706	CcSEcCtD
Cyproheptadine—Diarrhoea—Niacin—coronary artery disease	7.93e-05	0.000706	CcSEcCtD
Cyproheptadine—Asthenia—Enalapril—coronary artery disease	7.92e-05	0.000705	CcSEcCtD
Cyproheptadine—Headache—Simvastatin—coronary artery disease	7.9e-05	0.000704	CcSEcCtD
Cyproheptadine—Dizziness—Valsartan—coronary artery disease	7.88e-05	0.000701	CcSEcCtD
Cyproheptadine—Anorexia—Ramipril—coronary artery disease	7.88e-05	0.000701	CcSEcCtD
Cyproheptadine—Nausea—Ezetimibe—coronary artery disease	7.86e-05	0.0007	CcSEcCtD
Cyproheptadine—Dizziness—Olmesartan—coronary artery disease	7.84e-05	0.000698	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Timolol—coronary artery disease	7.81e-05	0.000695	CcSEcCtD
Cyproheptadine—Asthenia—Telmisartan—coronary artery disease	7.81e-05	0.000695	CcSEcCtD
Cyproheptadine—Diarrhoea—Pravastatin—coronary artery disease	7.81e-05	0.000695	CcSEcCtD
Cyproheptadine—Hypotension—Ramipril—coronary artery disease	7.72e-05	0.000687	CcSEcCtD
Cyproheptadine—Anorexia—Timolol—coronary artery disease	7.7e-05	0.000685	CcSEcCtD
Cyproheptadine—Nausea—Eplerenone—coronary artery disease	7.69e-05	0.000685	CcSEcCtD
Cyproheptadine—Dizziness—Niacin—coronary artery disease	7.66e-05	0.000682	CcSEcCtD
Cyproheptadine—Urticaria—Losartan—coronary artery disease	7.66e-05	0.000681	CcSEcCtD
Cyproheptadine—Asthenia—Captopril—coronary artery disease	7.59e-05	0.000676	CcSEcCtD
Cyproheptadine—Diarrhoea—Trandolapril—coronary artery disease	7.58e-05	0.000675	CcSEcCtD
Cyproheptadine—Vomiting—Valsartan—coronary artery disease	7.58e-05	0.000674	CcSEcCtD
Cyproheptadine—Confusional state—Lisinopril—coronary artery disease	7.56e-05	0.000673	CcSEcCtD
Cyproheptadine—Diarrhoea—Enalapril—coronary artery disease	7.55e-05	0.000672	CcSEcCtD
Cyproheptadine—Hypotension—Timolol—coronary artery disease	7.55e-05	0.000672	CcSEcCtD
Cyproheptadine—Dizziness—Pravastatin—coronary artery disease	7.54e-05	0.000671	CcSEcCtD
Cyproheptadine—Vomiting—Olmesartan—coronary artery disease	7.54e-05	0.000671	CcSEcCtD
Cyproheptadine—Rash—Valsartan—coronary artery disease	7.51e-05	0.000669	CcSEcCtD
Cyproheptadine—Dermatitis—Valsartan—coronary artery disease	7.51e-05	0.000668	CcSEcCtD
Cyproheptadine—Nausea—Simvastatin—coronary artery disease	7.5e-05	0.000667	CcSEcCtD
Cyproheptadine—Oedema—Lisinopril—coronary artery disease	7.49e-05	0.000667	CcSEcCtD
Cyproheptadine—Rash—Olmesartan—coronary artery disease	7.48e-05	0.000666	CcSEcCtD
Cyproheptadine—Insomnia—Ramipril—coronary artery disease	7.47e-05	0.000665	CcSEcCtD
Cyproheptadine—Dermatitis—Olmesartan—coronary artery disease	7.47e-05	0.000665	CcSEcCtD
Cyproheptadine—Headache—Valsartan—coronary artery disease	7.47e-05	0.000664	CcSEcCtD
Cyproheptadine—Diarrhoea—Telmisartan—coronary artery disease	7.45e-05	0.000663	CcSEcCtD
Cyproheptadine—Headache—Olmesartan—coronary artery disease	7.43e-05	0.000661	CcSEcCtD
Cyproheptadine—Paraesthesia—Ramipril—coronary artery disease	7.42e-05	0.000661	CcSEcCtD
Cyproheptadine—Shock—Lisinopril—coronary artery disease	7.37e-05	0.000656	CcSEcCtD
Cyproheptadine—Asthenia—Perindopril—coronary artery disease	7.37e-05	0.000656	CcSEcCtD
Cyproheptadine—Vomiting—Niacin—coronary artery disease	7.37e-05	0.000656	CcSEcCtD
Cyproheptadine—Somnolence—Ramipril—coronary artery disease	7.35e-05	0.000654	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Lisinopril—coronary artery disease	7.34e-05	0.000653	CcSEcCtD
Cyproheptadine—Dizziness—Trandolapril—coronary artery disease	7.33e-05	0.000652	CcSEcCtD
Cyproheptadine—Tachycardia—Lisinopril—coronary artery disease	7.31e-05	0.000651	CcSEcCtD
Cyproheptadine—Insomnia—Timolol—coronary artery disease	7.31e-05	0.00065	CcSEcCtD
Cyproheptadine—Rash—Niacin—coronary artery disease	7.31e-05	0.00065	CcSEcCtD
Cyproheptadine—Dermatitis—Niacin—coronary artery disease	7.3e-05	0.00065	CcSEcCtD
Cyproheptadine—Dizziness—Enalapril—coronary artery disease	7.3e-05	0.000649	CcSEcCtD
Cyproheptadine—Dyspepsia—Ramipril—coronary artery disease	7.27e-05	0.000647	CcSEcCtD
Cyproheptadine—Headache—Niacin—coronary artery disease	7.26e-05	0.000646	CcSEcCtD
Cyproheptadine—Paraesthesia—Timolol—coronary artery disease	7.25e-05	0.000646	CcSEcCtD
Cyproheptadine—Vomiting—Pravastatin—coronary artery disease	7.25e-05	0.000646	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Lisinopril—coronary artery disease	7.25e-05	0.000645	CcSEcCtD
Cyproheptadine—Diarrhoea—Captopril—coronary artery disease	7.24e-05	0.000645	CcSEcCtD
Cyproheptadine—Dizziness—Telmisartan—coronary artery disease	7.2e-05	0.000641	CcSEcCtD
Cyproheptadine—Rash—Pravastatin—coronary artery disease	7.19e-05	0.00064	CcSEcCtD
Cyproheptadine—Dermatitis—Pravastatin—coronary artery disease	7.19e-05	0.00064	CcSEcCtD
Cyproheptadine—Decreased appetite—Ramipril—coronary artery disease	7.18e-05	0.000639	CcSEcCtD
Cyproheptadine—Somnolence—Timolol—coronary artery disease	7.18e-05	0.000639	CcSEcCtD
Cyproheptadine—Asthenia—Furosemide—coronary artery disease	7.17e-05	0.000638	CcSEcCtD
Cyproheptadine—Headache—Pravastatin—coronary artery disease	7.15e-05	0.000636	CcSEcCtD
Cyproheptadine—Anorexia—Lisinopril—coronary artery disease	7.14e-05	0.000636	CcSEcCtD
Cyproheptadine—Fatigue—Ramipril—coronary artery disease	7.12e-05	0.000634	CcSEcCtD
Cyproheptadine—Dyspepsia—Timolol—coronary artery disease	7.11e-05	0.000633	CcSEcCtD
Cyproheptadine—Mianserin—HTR7—coronary artery disease	7.11e-05	0.0214	CrCbGaD
Cyproheptadine—Nausea—Valsartan—coronary artery disease	7.08e-05	0.00063	CcSEcCtD
Cyproheptadine—Constipation—Ramipril—coronary artery disease	7.07e-05	0.000629	CcSEcCtD
Cyproheptadine—Nausea—Olmesartan—coronary artery disease	7.04e-05	0.000627	CcSEcCtD
Cyproheptadine—Vomiting—Trandolapril—coronary artery disease	7.04e-05	0.000627	CcSEcCtD
Cyproheptadine—Diarrhoea—Perindopril—coronary artery disease	7.03e-05	0.000626	CcSEcCtD
Cyproheptadine—Decreased appetite—Timolol—coronary artery disease	7.02e-05	0.000625	CcSEcCtD
Cyproheptadine—Vomiting—Enalapril—coronary artery disease	7.02e-05	0.000624	CcSEcCtD
Cyproheptadine—Hypotension—Lisinopril—coronary artery disease	7e-05	0.000623	CcSEcCtD
Cyproheptadine—Dizziness—Captopril—coronary artery disease	7e-05	0.000623	CcSEcCtD
Cyproheptadine—Rash—Trandolapril—coronary artery disease	6.98e-05	0.000622	CcSEcCtD
Cyproheptadine—Dermatitis—Trandolapril—coronary artery disease	6.98e-05	0.000621	CcSEcCtD
Cyproheptadine—Fatigue—Timolol—coronary artery disease	6.97e-05	0.00062	CcSEcCtD
Cyproheptadine—Rash—Enalapril—coronary artery disease	6.96e-05	0.000619	CcSEcCtD
Cyproheptadine—Dermatitis—Enalapril—coronary artery disease	6.95e-05	0.000619	CcSEcCtD
Cyproheptadine—Headache—Trandolapril—coronary artery disease	6.94e-05	0.000618	CcSEcCtD
Cyproheptadine—Vomiting—Telmisartan—coronary artery disease	6.92e-05	0.000616	CcSEcCtD
Cyproheptadine—Asthenia—Losartan—coronary artery disease	6.91e-05	0.000615	CcSEcCtD
Cyproheptadine—Headache—Enalapril—coronary artery disease	6.91e-05	0.000615	CcSEcCtD
Cyproheptadine—Nausea—Niacin—coronary artery disease	6.88e-05	0.000613	CcSEcCtD
Cyproheptadine—Rash—Telmisartan—coronary artery disease	6.86e-05	0.000611	CcSEcCtD
Cyproheptadine—Dermatitis—Telmisartan—coronary artery disease	6.86e-05	0.00061	CcSEcCtD
Cyproheptadine—Amitriptyline—OPRD1—coronary artery disease	6.84e-05	0.0206	CrCbGaD
Cyproheptadine—Diarrhoea—Furosemide—coronary artery disease	6.83e-05	0.000608	CcSEcCtD
Cyproheptadine—Headache—Telmisartan—coronary artery disease	6.82e-05	0.000607	CcSEcCtD
Cyproheptadine—Feeling abnormal—Ramipril—coronary artery disease	6.81e-05	0.000606	CcSEcCtD
Cyproheptadine—Dizziness—Perindopril—coronary artery disease	6.79e-05	0.000605	CcSEcCtD
Cyproheptadine—Insomnia—Lisinopril—coronary artery disease	6.78e-05	0.000603	CcSEcCtD
Cyproheptadine—Nausea—Pravastatin—coronary artery disease	6.78e-05	0.000603	CcSEcCtD
Cyproheptadine—Paraesthesia—Lisinopril—coronary artery disease	6.73e-05	0.000599	CcSEcCtD
Cyproheptadine—Vomiting—Captopril—coronary artery disease	6.73e-05	0.000599	CcSEcCtD
Cyproheptadine—Rash—Captopril—coronary artery disease	6.67e-05	0.000594	CcSEcCtD
Cyproheptadine—Dermatitis—Captopril—coronary artery disease	6.67e-05	0.000593	CcSEcCtD
Cyproheptadine—Somnolence—Lisinopril—coronary artery disease	6.66e-05	0.000593	CcSEcCtD
Cyproheptadine—Feeling abnormal—Timolol—coronary artery disease	6.66e-05	0.000593	CcSEcCtD
Cyproheptadine—Headache—Captopril—coronary artery disease	6.63e-05	0.00059	CcSEcCtD
Cyproheptadine—Dizziness—Furosemide—coronary artery disease	6.61e-05	0.000588	CcSEcCtD
Cyproheptadine—Dyspepsia—Lisinopril—coronary artery disease	6.6e-05	0.000587	CcSEcCtD
Cyproheptadine—Diarrhoea—Losartan—coronary artery disease	6.59e-05	0.000587	CcSEcCtD
Cyproheptadine—Nausea—Trandolapril—coronary artery disease	6.58e-05	0.000586	CcSEcCtD
Cyproheptadine—Urticaria—Ramipril—coronary artery disease	6.56e-05	0.000584	CcSEcCtD
Cyproheptadine—Nausea—Enalapril—coronary artery disease	6.55e-05	0.000583	CcSEcCtD
Cyproheptadine—Vomiting—Perindopril—coronary artery disease	6.53e-05	0.000582	CcSEcCtD
Cyproheptadine—Decreased appetite—Lisinopril—coronary artery disease	6.51e-05	0.00058	CcSEcCtD
Cyproheptadine—Rash—Perindopril—coronary artery disease	6.48e-05	0.000577	CcSEcCtD
Cyproheptadine—Dermatitis—Perindopril—coronary artery disease	6.47e-05	0.000576	CcSEcCtD
Cyproheptadine—Nausea—Telmisartan—coronary artery disease	6.46e-05	0.000575	CcSEcCtD
Cyproheptadine—Fatigue—Lisinopril—coronary artery disease	6.46e-05	0.000575	CcSEcCtD
Cyproheptadine—Headache—Perindopril—coronary artery disease	6.44e-05	0.000573	CcSEcCtD
Cyproheptadine—Urticaria—Timolol—coronary artery disease	6.42e-05	0.000571	CcSEcCtD
Cyproheptadine—Constipation—Lisinopril—coronary artery disease	6.41e-05	0.00057	CcSEcCtD
Cyproheptadine—Dizziness—Losartan—coronary artery disease	6.37e-05	0.000567	CcSEcCtD
Cyproheptadine—Vomiting—Furosemide—coronary artery disease	6.35e-05	0.000565	CcSEcCtD
Cyproheptadine—Rash—Furosemide—coronary artery disease	6.3e-05	0.000561	CcSEcCtD
Cyproheptadine—Dermatitis—Furosemide—coronary artery disease	6.29e-05	0.00056	CcSEcCtD
Cyproheptadine—Nausea—Captopril—coronary artery disease	6.29e-05	0.00056	CcSEcCtD
Cyproheptadine—Headache—Furosemide—coronary artery disease	6.26e-05	0.000557	CcSEcCtD
Cyproheptadine—Cyclobenzaprine—HTR2A—coronary artery disease	6.22e-05	0.0187	CrCbGaD
Cyproheptadine—Feeling abnormal—Lisinopril—coronary artery disease	6.18e-05	0.00055	CcSEcCtD
Cyproheptadine—Vomiting—Losartan—coronary artery disease	6.13e-05	0.000545	CcSEcCtD
Cyproheptadine—Nausea—Perindopril—coronary artery disease	6.1e-05	0.000543	CcSEcCtD
Cyproheptadine—Rash—Losartan—coronary artery disease	6.08e-05	0.000541	CcSEcCtD
Cyproheptadine—Dermatitis—Losartan—coronary artery disease	6.07e-05	0.00054	CcSEcCtD
Cyproheptadine—Headache—Losartan—coronary artery disease	6.04e-05	0.000537	CcSEcCtD
Cyproheptadine—Urticaria—Lisinopril—coronary artery disease	5.95e-05	0.00053	CcSEcCtD
Cyproheptadine—Nausea—Furosemide—coronary artery disease	5.93e-05	0.000528	CcSEcCtD
Cyproheptadine—Asthenia—Ramipril—coronary artery disease	5.93e-05	0.000528	CcSEcCtD
Cyproheptadine—Asthenia—Timolol—coronary artery disease	5.8e-05	0.000516	CcSEcCtD
Cyproheptadine—Nausea—Losartan—coronary artery disease	5.72e-05	0.00051	CcSEcCtD
Cyproheptadine—Diarrhoea—Ramipril—coronary artery disease	5.65e-05	0.000503	CcSEcCtD
Cyproheptadine—Loxapine—HTR7—coronary artery disease	5.65e-05	0.017	CrCbGaD
Cyproheptadine—Diarrhoea—Timolol—coronary artery disease	5.53e-05	0.000492	CcSEcCtD
Cyproheptadine—Dizziness—Ramipril—coronary artery disease	5.46e-05	0.000486	CcSEcCtD
Cyproheptadine—Asthenia—Lisinopril—coronary artery disease	5.38e-05	0.000479	CcSEcCtD
Cyproheptadine—Dizziness—Timolol—coronary artery disease	5.34e-05	0.000476	CcSEcCtD
Cyproheptadine—Vomiting—Ramipril—coronary artery disease	5.25e-05	0.000468	CcSEcCtD
Cyproheptadine—Rash—Ramipril—coronary artery disease	5.21e-05	0.000464	CcSEcCtD
Cyproheptadine—Dermatitis—Ramipril—coronary artery disease	5.21e-05	0.000463	CcSEcCtD
Cyproheptadine—Headache—Ramipril—coronary artery disease	5.18e-05	0.000461	CcSEcCtD
Cyproheptadine—Vomiting—Timolol—coronary artery disease	5.14e-05	0.000457	CcSEcCtD
Cyproheptadine—Diarrhoea—Lisinopril—coronary artery disease	5.13e-05	0.000456	CcSEcCtD
Cyproheptadine—Rash—Timolol—coronary artery disease	5.09e-05	0.000453	CcSEcCtD
Cyproheptadine—Dermatitis—Timolol—coronary artery disease	5.09e-05	0.000453	CcSEcCtD
Cyproheptadine—Headache—Timolol—coronary artery disease	5.06e-05	0.00045	CcSEcCtD
Cyproheptadine—Dizziness—Lisinopril—coronary artery disease	4.96e-05	0.000441	CcSEcCtD
Cyproheptadine—Nausea—Ramipril—coronary artery disease	4.91e-05	0.000437	CcSEcCtD
Cyproheptadine—Loxapine—ADRB1—coronary artery disease	4.84e-05	0.0145	CrCbGaD
Cyproheptadine—Nausea—Timolol—coronary artery disease	4.8e-05	0.000427	CcSEcCtD
Cyproheptadine—Carbamazepine—CYP2C19—coronary artery disease	4.78e-05	0.0144	CrCbGaD
Cyproheptadine—Vomiting—Lisinopril—coronary artery disease	4.77e-05	0.000424	CcSEcCtD
Cyproheptadine—Clozapine—HTR7—coronary artery disease	4.74e-05	0.0142	CrCbGaD
Cyproheptadine—Rash—Lisinopril—coronary artery disease	4.73e-05	0.000421	CcSEcCtD
Cyproheptadine—Dermatitis—Lisinopril—coronary artery disease	4.72e-05	0.00042	CcSEcCtD
Cyproheptadine—Headache—Lisinopril—coronary artery disease	4.69e-05	0.000418	CcSEcCtD
Cyproheptadine—Nausea—Lisinopril—coronary artery disease	4.45e-05	0.000396	CcSEcCtD
Cyproheptadine—Amitriptyline—HTR7—coronary artery disease	4.41e-05	0.0132	CrCbGaD
Cyproheptadine—Nortriptyline—CYP2C19—coronary artery disease	3.94e-05	0.0118	CrCbGaD
Cyproheptadine—Mianserin—HTR2A—coronary artery disease	3.57e-05	0.0107	CrCbGaD
Cyproheptadine—Nortriptyline—HTR2A—coronary artery disease	3.19e-05	0.0096	CrCbGaD
Cyproheptadine—Clozapine—CYP2C19—coronary artery disease	2.94e-05	0.00884	CrCbGaD
Cyproheptadine—Loxapine—HTR2A—coronary artery disease	2.84e-05	0.00853	CrCbGaD
Cyproheptadine—Amitriptyline—CYP2C19—coronary artery disease	2.73e-05	0.00822	CrCbGaD
Cyproheptadine—Clozapine—HTR2A—coronary artery disease	2.38e-05	0.00716	CrCbGaD
Cyproheptadine—Amitriptyline—HTR2A—coronary artery disease	2.22e-05	0.00666	CrCbGaD
Cyproheptadine—Nortriptyline—ALB—coronary artery disease	2.19e-05	0.00657	CrCbGaD
Cyproheptadine—Amitriptyline—ALB—coronary artery disease	1.52e-05	0.00456	CrCbGaD
Cyproheptadine—DRD2—Signaling Pathways—NFKBIA—coronary artery disease	1.82e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—MAPK1—coronary artery disease	1.82e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ESR1—coronary artery disease	1.82e-06	2.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—F2—coronary artery disease	1.82e-06	2.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FN1—coronary artery disease	1.82e-06	2.16e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—F2—coronary artery disease	1.81e-06	2.16e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FN1—coronary artery disease	1.81e-06	2.16e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MMP9—coronary artery disease	1.81e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6ST—coronary artery disease	1.81e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—F2—coronary artery disease	1.81e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FN1—coronary artery disease	1.81e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ESR1—coronary artery disease	1.81e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6ST—coronary artery disease	1.81e-06	2.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—F2—coronary artery disease	1.8e-06	2.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FN1—coronary artery disease	1.8e-06	2.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	1.8e-06	2.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NFKBIA—coronary artery disease	1.79e-06	2.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	1.79e-06	2.13e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NFKBIA—coronary artery disease	1.79e-06	2.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—ALB—coronary artery disease	1.79e-06	2.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	1.79e-06	2.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FN1—coronary artery disease	1.78e-06	2.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—F2—coronary artery disease	1.78e-06	2.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	1.78e-06	2.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	1.78e-06	2.11e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—KIT—coronary artery disease	1.77e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKT1—coronary artery disease	1.76e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	1.76e-06	2.1e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKT1—coronary artery disease	1.76e-06	2.09e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.75e-06	2.08e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	1.75e-06	2.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CASP3—coronary artery disease	1.75e-06	2.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—PIK3CA—coronary artery disease	1.74e-06	2.07e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—SERPINE1—coronary artery disease	1.74e-06	2.07e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—KIT—coronary artery disease	1.74e-06	2.07e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—coronary artery disease	1.74e-06	2.07e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—KIT—coronary artery disease	1.73e-06	2.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—KIT—coronary artery disease	1.73e-06	2.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—KIT—coronary artery disease	1.72e-06	2.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—NOS3—coronary artery disease	1.71e-06	2.03e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—KIT—coronary artery disease	1.71e-06	2.03e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCND1—coronary artery disease	1.7e-06	2.02e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—GSK3B—coronary artery disease	1.7e-06	2.02e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—FGF2—coronary artery disease	1.69e-06	2.01e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—FGF2—coronary artery disease	1.68e-06	2e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—POMC—coronary artery disease	1.68e-06	2e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CREB1—coronary artery disease	1.68e-06	2e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOS3—coronary artery disease	1.67e-06	1.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—GSK3B—coronary artery disease	1.67e-06	1.98e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—GSK3B—coronary artery disease	1.66e-06	1.98e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOS3—coronary artery disease	1.66e-06	1.98e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	1.66e-06	1.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—POMC—coronary artery disease	1.65e-06	1.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CREB1—coronary artery disease	1.65e-06	1.97e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	1.65e-06	1.97e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MMP9—coronary artery disease	1.65e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CREB1—coronary artery disease	1.65e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—POMC—coronary artery disease	1.65e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—POMC—coronary artery disease	1.65e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CREB1—coronary artery disease	1.65e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL2—coronary artery disease	1.65e-06	1.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—POMC—coronary artery disease	1.64e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CREB1—coronary artery disease	1.64e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6R—coronary artery disease	1.64e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	1.64e-06	1.95e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—coronary artery disease	1.63e-06	1.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—POMC—coronary artery disease	1.62e-06	1.93e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CREB1—coronary artery disease	1.62e-06	1.93e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—JAK2—coronary artery disease	1.62e-06	1.93e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL2—coronary artery disease	1.62e-06	1.93e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1—coronary artery disease	1.62e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL2—coronary artery disease	1.62e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—JAK2—coronary artery disease	1.61e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6R—coronary artery disease	1.61e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6R—coronary artery disease	1.61e-06	1.92e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL2—coronary artery disease	1.61e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—MAPK1—coronary artery disease	1.61e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6R—coronary artery disease	1.61e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL2—coronary artery disease	1.6e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—coronary artery disease	1.6e-06	1.91e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6R—coronary artery disease	1.6e-06	1.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1—coronary artery disease	1.59e-06	1.89e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.59e-06	1.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL2—coronary artery disease	1.59e-06	1.89e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1—coronary artery disease	1.59e-06	1.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6R—coronary artery disease	1.58e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—MAPK1—coronary artery disease	1.58e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1—coronary artery disease	1.58e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—PIK3CA—coronary artery disease	1.58e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—MAPK1—coronary artery disease	1.58e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1—coronary artery disease	1.58e-06	1.88e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	1.58e-06	1.87e-05	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—coronary artery disease	1.57e-06	1.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	1.57e-06	1.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—coronary artery disease	1.56e-06	1.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1—coronary artery disease	1.56e-06	1.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	1.56e-06	1.85e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.54e-06	1.83e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—SERPINE1—coronary artery disease	1.54e-06	1.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.51e-06	1.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—SERPINE1—coronary artery disease	1.51e-06	1.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.51e-06	1.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—SERPINE1—coronary artery disease	1.51e-06	1.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.51e-06	1.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	1.5e-06	1.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	1.5e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	1.5e-06	1.78e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—coronary artery disease	1.49e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—FGF2—coronary artery disease	1.49e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.49e-06	1.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	1.48e-06	1.76e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—coronary artery disease	1.48e-06	1.76e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.48e-06	1.76e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CXCL8—coronary artery disease	1.47e-06	1.75e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOS3—coronary artery disease	1.47e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK1—coronary artery disease	1.46e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—FGF2—coronary artery disease	1.46e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—FGF2—coronary artery disease	1.46e-06	1.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—FGF2—coronary artery disease	1.46e-06	1.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—FGF2—coronary artery disease	1.45e-06	1.72e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOS3—coronary artery disease	1.44e-06	1.72e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOS3—coronary artery disease	1.44e-06	1.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—FGF2—coronary artery disease	1.44e-06	1.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOS3—coronary artery disease	1.44e-06	1.71e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.43e-06	1.7e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOS3—coronary artery disease	1.43e-06	1.7e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—JAK2—coronary artery disease	1.43e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—coronary artery disease	1.42e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.42e-06	1.69e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOS3—coronary artery disease	1.42e-06	1.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—coronary artery disease	1.41e-06	1.68e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.41e-06	1.68e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—JAK2—coronary artery disease	1.4e-06	1.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—coronary artery disease	1.4e-06	1.67e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—JAK2—coronary artery disease	1.4e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—PIK3CA—coronary artery disease	1.4e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—JAK2—coronary artery disease	1.39e-06	1.66e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—JAK2—coronary artery disease	1.39e-06	1.65e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.38e-06	1.64e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—JAK2—coronary artery disease	1.38e-06	1.64e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—PIK3CA—coronary artery disease	1.37e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCND1—coronary artery disease	1.37e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—PIK3CA—coronary artery disease	1.37e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	1.37e-06	1.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	1.36e-06	1.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—coronary artery disease	1.36e-06	1.62e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	1.35e-06	1.6e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.34e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK1—coronary artery disease	1.34e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MMP9—coronary artery disease	1.33e-06	1.59e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	1.3e-06	1.55e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.3e-06	1.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	1.29e-06	1.54e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	1.28e-06	1.52e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	1.28e-06	1.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	1.27e-06	1.51e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	1.27e-06	1.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	1.27e-06	1.51e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	1.26e-06	1.49e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	1.26e-06	1.49e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—coronary artery disease	1.24e-06	1.48e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—coronary artery disease	1.24e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	1.24e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	1.23e-06	1.47e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	1.23e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	1.23e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	1.22e-06	1.46e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—coronary artery disease	1.22e-06	1.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—coronary artery disease	1.22e-06	1.45e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	1.22e-06	1.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—coronary artery disease	1.21e-06	1.44e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—coronary artery disease	1.21e-06	1.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	1.21e-06	1.44e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCND1—coronary artery disease	1.21e-06	1.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—coronary artery disease	1.21e-06	1.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—coronary artery disease	1.21e-06	1.43e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.2e-06	1.43e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—coronary artery disease	1.2e-06	1.43e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	1.2e-06	1.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—coronary artery disease	1.19e-06	1.42e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	1.19e-06	1.42e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCND1—coronary artery disease	1.19e-06	1.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCND1—coronary artery disease	1.19e-06	1.41e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCND1—coronary artery disease	1.18e-06	1.41e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MMP9—coronary artery disease	1.18e-06	1.4e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCND1—coronary artery disease	1.17e-06	1.39e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—PIK3CA—coronary artery disease	1.16e-06	1.38e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	1.16e-06	1.38e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MMP9—coronary artery disease	1.16e-06	1.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MMP9—coronary artery disease	1.15e-06	1.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MMP9—coronary artery disease	1.15e-06	1.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	1.14e-06	1.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MMP9—coronary artery disease	1.14e-06	1.35e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—coronary artery disease	1.12e-06	1.34e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	1.12e-06	1.34e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	1.12e-06	1.33e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	1.12e-06	1.33e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	1.11e-06	1.32e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.1e-06	1.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	1.1e-06	1.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	1.1e-06	1.31e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.08e-06	1.29e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	1.08e-06	1.28e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	1.06e-06	1.26e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	1.04e-06	1.24e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	1.04e-06	1.23e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—coronary artery disease	1.04e-06	1.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	1.03e-06	1.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	1.03e-06	1.23e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—coronary artery disease	1.03e-06	1.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	1.02e-06	1.21e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	9.7e-07	1.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PIK3CA—coronary artery disease	9.63e-07	1.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	9.54e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	9.52e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	9.51e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	9.49e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—coronary artery disease	9.47e-07	1.13e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	9.46e-07	1.12e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	9.4e-07	1.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	9.37e-07	1.11e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	9.36e-07	1.11e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	9.35e-07	1.11e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	9.34e-07	1.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	9.31e-07	1.11e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	9.28e-07	1.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	9.19e-07	1.09e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—coronary artery disease	8.32e-07	9.9e-06	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—coronary artery disease	8.28e-07	9.85e-06	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	8.25e-07	9.81e-06	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	8.12e-07	9.65e-06	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	8.1e-07	9.63e-06	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	8.08e-07	9.6e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	8.05e-07	9.57e-06	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	7.97e-07	9.48e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—coronary artery disease	7.86e-07	9.35e-06	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	7.68e-07	9.13e-06	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	7.64e-07	9.08e-06	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—coronary artery disease	7.31e-07	8.69e-06	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—coronary artery disease	7.19e-07	8.55e-06	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—coronary artery disease	7.17e-07	8.53e-06	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—coronary artery disease	7.15e-07	8.5e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—coronary artery disease	7.13e-07	8.48e-06	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—coronary artery disease	7.06e-07	8.39e-06	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—coronary artery disease	6.74e-07	8.02e-06	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	6.63e-07	7.89e-06	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—coronary artery disease	6.62e-07	7.87e-06	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—coronary artery disease	6.6e-07	7.84e-06	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—coronary artery disease	6.58e-07	7.82e-06	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—coronary artery disease	6.51e-07	7.74e-06	CbGpPWpGaD
